Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05637905

Monocyte Chemoattractant Protein-1 in Psoriatic Arthritis Patients

Conditions: Psoriatic Arthritis

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: 1

Enrollment: 44

Sponsor: Assiut University

Summary

Evaluate serum levels of (MCP-1) in PsA with or without cardiovascular affaction .Detect subclinical cardiovascular affaction in patients with PsA for early diagnosis and management .

Eligibility Criteria

Inclusion Criteria:PsA patients (age ≥ 18years) who fulfilled the CASPAR classification criteria[15]for psoriatic arthritisExclusion Criteria:PsA patients withinfection.bone marrow disorders.other autoimmune diseases.diabetes.hypertention .hyperlipidemia.liver diseases.renal diseases.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05637905). StuddyBuddy aggregates publicly available trial information.